.... Prostate carcinoma Internet Guidelines Accordance Information behavior Information seeking An increasing number of patients are screening the internet for information on their disease [ 1 ]. As PCa displays the second most common malignancy worldwide, it seems logical that PCa is one...

... resistance Infection Prostate biopsy Prostate cancer Prostate carcinoma Transrectal ultrasonography Urinary tract infection Abstract Objective: The objective of this study was to determine the prevalence of antibiotic resistance in fecal flora of patients undergoing transrectal ultrasound-guided...

...K. Gyftopoulos; K. Vourda; G. Sakellaropoulos; P. Perimenis; A. Athanasopoulos; E. Papadaki Objective: Angiogenesis is essential for tumor growth and metastasis; however, angiogenic factors are not uniformly expressed in prostate carcinoma. Our aim was to determine the expression of vascular...

... sonography Benign prostatic hyperplasia Prostate carcinoma Abstract Digital rectal examination, prostate-specific antigen and transrectal sonography (TRS) are the main diagnostic tools for evaluating men at risk for carcinoma of the prostate (PCa). PCa has a hypoechoic echo pattern via TRS in 6085% of cases...

... parameters. Also, no significant association between p53 expression and prognosis was observed. p53 Tumor suppressor gene Immunohistochemistry Prostate carcinoma Urologia Internationalis Original Paper Urol Int 1997;58:199-202 Received: May 30, 1996 Accepted after revision: January 16, 1997 Onder...

... monoclonal antibody Prostate carcinoma Glycolipid Original Paper Urol Int 1992;48:20-24 Makoto Satoha Yasuo Fukushib Sadafwni Kawamuraa Chikara Ohyamaa Seiichi Saitoa Seiichi Orikasaa Edward Nudlemanc Sen-itiroh Hakamoric Glycolipid Expression in Prostatic Tissue and Analysis of the Antigen Recognized...

... from any ideas, methods, instructions or products referred to in the content or advertisements. Cancer genetics Tumor suppressor genes RB gene p53gene Tumour progression Prognosis Bladder carcinoma Prostate carcinoma Urological tumours Original Paper Urol Int 1994;53:1-5 J.M. W olff...

... subjective improvement for 2 months. However, during the 3rd month of treatment there was global deterioration which progressed further till his demise during the 4th month. The beneficial role, if any, of combined hormonal and immunotherapy in advanced prostatic carcinoma is discussed as also the natural...

... in a Patient with Metastatic Prostate Adenocarcinoma Key Words Malignant priapism Prostate carcinoma Diagnostics Abstract Métastasés to the penis due to a primary carcinoma o f the prostate are rare. In approximately half o f the patients, malignant priapism is the main symptom. This study reports on a case o...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostate Prostate carcinoma Prostate neoplasm Case Report Urol Int 1994;52:48-51 NarendraA. Jadeja Prem Nath Dogra...

...: incidence, growth, characteristics and clinical significance. J. Urol. 101: 602 (1969). 9 Del-Regato, J.A.: Radiotherapy in the curative treatment of operable locally inoperable carcinoma o f the prostate. Radiology 88: 761 (1967). 10 Hill, D.R.; Crews, Q.E.; Walsh, P.C.: Prostate carcinoma: radia­ tion...

... to attain further improvement of the actuarial survival in metastatic prostate carcinoma. Prostate carcinoma Specific immunotherapy Urol. int. 42: 292-294(1987) © 1987 S. Karger AG. Basel 0 0 4 2 -1 138/87/0424-0292S2.75/0 Late Results of Complementary Specific Immunostimulation in Metastatic...

...Boaz Moskovitz; Hedviga Kerner; Dan Richter Levin In 1 out of 56 patients, orchiectomized in the course of treatment for prostatic carcinoma, metastatic growth in the testis was found. This uncommon metastatic spread is a sign of advanced disease. 30 09 1986 14 10 1986 2 2 2010...

... increase in the survival rate during treatment of unconfined metastasizing prostate carcinomas. Even in early stages specific immunotherapy constitutes a new alternative therapeutic method, particularly in the treatment of hormone-independent prostate carcinomas and in cases of estrogen intolerance. 23...

... less encouraging in other neoplasms, where only a limited number of transient regressions and subjective improvements can be observed. Kidney carcinoma Bladder carcinoma Prostate carcinoma Testis tumours Alkylating agents Antimetabolites Antitumour antibiotics Progesterone Urol. int. 26...

... and Unaltered Total Ghrelin and Obestatin Concentrations in Prostate Carcinoma Witold Malendowicza Agnieszka Ziolkowskab Marta Szyszkab Zbigniew Kwiasa Departments of aUrology and Urooncology and bHistology and Embryology, Poznan University of Medical Sciences, Poznan, Poland Key Words Benign prostate...

... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostate carcinoma Transitional...

.... The bcl 2 expression was a characteristic of the tumors of patients who later died. These results show that the degree of induction of apoptosis in prostate carcinoma by hormonal therapy varies from case to case. A given prostate cancer patient’s response to therapy may be predicted by following apoptotic...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostate carcinoma Prostate-specific antigen Malignant pleural effusion Gordon A. Brown Phillip C. Ginsberg Richard C. Harkaway Albert Einstein Medical Center...